255 related articles for article (PubMed ID: 3926898)
1. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
Edelman AS; Xue B; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
Edelman AS; Xue B; Galton JE; Sanchez P; Thorbecke GJ
J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899
[TBL] [Abstract][Full Text] [Related]
3. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. III. Tumor growth inhibition by local delayed hypersensitivity reactions to unrelated antigens.
Palladino MA; Thorbecke GJ
Eur J Immunol; 1978 Apr; 8(4):257-62. PubMed ID: 668800
[TBL] [Abstract][Full Text] [Related]
4. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
[TBL] [Abstract][Full Text] [Related]
5. Immunity to carcinogen-induced transplantable fibrosarcoma in B2/B2 chickens. V. Relationship to tumor cell-specific delayed hypersensitivity and serum antibody.
Galton JE; Palladino MA; Xue B; Edelman AS; Thorbecke GJ
Cell Immunol; 1982 Nov; 73(2):247-63. PubMed ID: 6186403
[No Abstract] [Full Text] [Related]
6. Derivation of transplantable 7,12-dimethylbenz[a]anthracene-induced chicken fibrosarcoma lines: differences in metastasizing properties and organ specificity.
Galton JE; Xue B; Hochwald GM; Thorbecke GJ
J Natl Cancer Inst; 1982 Aug; 69(2):535-41. PubMed ID: 6810007
[TBL] [Abstract][Full Text] [Related]
7. Chemical carcinogen-induced transplantable fibrosarcomas in histocompatible chickens. II. Effect of age and thymectomy on tumor incidence.
Hirota Y; Galton J; Lerman SP; Palladino MA; Thorbecke GJ
J Natl Cancer Inst; 1980 Sep; 65(3):595-601. PubMed ID: 6774152
[TBL] [Abstract][Full Text] [Related]
8. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
9. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
10. src-specific immune regression of Rous sarcoma virus-induced tumors.
Gelman IH; Hanafusa H
Cancer Res; 1993 Feb; 53(4):915-20. PubMed ID: 8381333
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
Flood PM; Schreiber H; Ron Y
J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of guinea pig cells transformed in culture by chemical carcinogens.
Ohanian SH; McCabe RP; Evans CH
J Natl Cancer Inst; 1981 Dec; 67(6):1363-8. PubMed ID: 6273639
[TBL] [Abstract][Full Text] [Related]
13. Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.
Shima J; Yoshioka T; Kosugi A; Ogata M; Fujiwara H; Hamaoka T; Ueda S; Kato S
Biken J; 1987 Mar; 30(1):1-8. PubMed ID: 2445335
[TBL] [Abstract][Full Text] [Related]
14. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
Economou GC; Takelchi N; Boone CW
Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
[TBL] [Abstract][Full Text] [Related]
15. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
LeGrue SJ; Ananthaswamy HN; Simcik WJ
Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
[TBL] [Abstract][Full Text] [Related]
16. Immunity to transplantable carcinogen-induced fibrosarcomas in B2/B2 chickens. I. Use of bacterial adjuvants in induction of immunity demonstrable in Winn tests.
Palladino MA; Thorbecke GJ
Cell Immunol; 1978 Jul; 38(2):336-49. PubMed ID: 354799
[No Abstract] [Full Text] [Related]
17. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of T cells from tumor-immune chickens to carcinogen-induced fibrosarcoma cells.
Quere P; Tsiagbe VK; Thorbecke GJ
Int J Cancer; 1990 Jun; 45(6):1159-63. PubMed ID: 2112514
[TBL] [Abstract][Full Text] [Related]
19. Suppressed cellular immunity in mice harboring intraocular melanomas.
Niederkorn JY
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):447-54. PubMed ID: 6608506
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
